Whistleblower cases which are related to allegations of pharmaceutical fraud in the United States are filed under the False Claims Act. The False Claims Act dates back to 1863 and has been used to collect billions in whistleblower rewards, more than 60% of the proceeds of which have come from the pharmaceutical industry. Whistleblower cases filed under the False Claims Act are filed under a federal seal, which is a court order that serves to protect the identity of the whistleblower from the defendants, and the public at large. This seal is generally extended for periods of 12 to 36 months, and at times far longer, during which the whistleblower remains completely anonymous to the defendants and the public eye.
Because of the protection and initial anonymity afforded to whistleblowers under the False Claims Act, many whistleblowers are able to come forward and report fraud while still remaining employed by the defendant. The False Claims Act provides the government powerful tools to investigate credible allegations of fraud, and whistleblowers often provide invaluable information on a successful False Claims Act case.
Whistleblower Justice Network works with our clients to ensure that they are provided the maximum protection under the law, both in terms of maintaining their privacy and pursuing their whistleblower case to the fullest extent of their rights. Whistleblower cases are complex litigation with a host of potential issues, and whether a whistleblower’s identity is ever made public is based on numerous factors.
If you have significant information about pharmaceutical fraud, Whistleblower Justice Network can help you become a successful whistleblower. Our clients benefit from our expertise, extensive relationships and 20+ years of combined experience as whistleblowers. Contact us today for your free, 100% confidential consultation.
